1. Management of immune checkpoint inhibitor-induced polymyalgia rheumatica

   van der Geest, K. S. M., Sandovici, M., Rutgers, A., Hiltermann, T. J. N., Oosting, S. F., Slart, R. H. J. A. & Brouwer, E., 4-Sep-2020, In : Annals of the Rheumatic Diseases. 2 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2. Adherence and Concordance between Serious Illness Care Planning Conversations and Oncology Clinician Documentation among Patients with Advanced Cancer

   Geerse, O. P., Lamas, D. J., Bernacki, R. E., Sanders, J. J., Paladino, J., Berendsen, A. J., Hiltermann, T. J. N., Lindvall, C., Fromme, E. K. & Block, S. D., 22-Jun-2020, In : Journal of Palliative Medicine. 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes

   Hurkmans, D. P., Tamminga, M., van Es, B., Peters, T., Karman, W., van Wijck, R. T. A., van der Spek, P. J., Tauber, T., Los, M., van Schetsen, A., Vu, T., Hiltermann, T. J. N., Schuuring, E., Aerts, J. G. J. V., Chen, S. & Groen, H. J. M., Aug-2020, In : Lung Cancer. 146, p. 341-349 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Immune microenvironment composition in non-small cell lung cancer and its association with survival

   Tamminga, M., Hiltermann, T. J. N., Schuuring, E., Timens, W., Fehrmann, R. S. N. & Groen, H. J. M., 12-Jun-2020, In : Clinical & translational immunology. 9, 6, 13 p., 1142.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation

   Meng, P., Koopman, B., Kok, K., Elst, ter, A., Schuuring, E., van Kempen, L., Timens, W., Hiltermann, J., Groen, H. J. M., van den Berg, A. & van der Wekken, A. J., Aug-2020, In : Lung Cancer. 146, p. 358-361 4 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (96) »

1. Treatment, pharmacological and non-pharmacological of lung cancer

   Jeroen Hiltermann (Invited speaker)

   22-Jun-2018

   Activity: Talk or presentation › Professional

2. Behandeling van Immunotherapie gerelateerde bijwerkingen met nadruk op de immuun gerelateerde pneumonitis

   Jeroen Hiltermann (Invited speaker)

   18-Sep-2018

   Activity: Talk or presentation › Professional

3. WCLC Toronto 2019

   Jeroen Hiltermann (Participant)

   22-Sep-2018 → 29-Sep-2018

   Activity: Participating in or organising an event › Participation in conference › Professional

View all (27) »